Ownership history in 2Xideas AG · 21 quarters on record
This page tracks every 13F SEC filing in which 2Xideas AG reported a position in RESMED INC (RMD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 74,215 | -9,396 | -11.2% | 5.01% | $17.9M | $240.31 |
| 2025 Q3 | ADDED | 83,611 | +8,397 | +11.2% | 4.83% | $22.9M | $272.45 |
| 2025 Q2 | REDUCED | 75,214 | -4,108 | -5.2% | 3.34% | $19.4M | $256.26 |
| 2025 Q1 | REDUCED | 79,322 | -14,183 | -15.2% | 2.70% | $17.8M | $221.86 |
| 2024 Q4 | REDUCED | 93,505 | -40,752 | -30.4% | 2.86% | $21.4M | $226.15 |
| 2024 Q3 | REDUCED | 134,257 | -16,781 | -11.1% | 4.42% | $32.8M | $240.88 |
| 2024 Q2 | REDUCED | 151,038 | -205,096 | -57.6% | 3.61% | $28.9M | $188.43 |
| 2024 Q1 | ADDED | 356,134 | +47,103 | +15.2% | 2.45% | $19.8M | $194.51 |
| 2023 Q4 | ADDED | 309,031 | +8,294 | +2.8% | 5.70% | $53.2M | $168.53 |
| 2023 Q3 | ADDED | 300,737 | +23,508 | +8.5% | 4.86% | $44.5M | $144.41 |
As of 2025 Q4 — sorted by position size